Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy (Q80277048)
Jump to navigation
Jump to search
scientific article published on 15 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy |
scientific article published on 15 September 2006 |
Statements
Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy (English)
R Baz
E Walker
M A Karam
T K Choueiri
R A Jawde
K Bruening
J Reed
B Faiman
Y Ellis
C Brand
G Srkalovic
S Andresen
R Knight
J Zeldis
15 September 2006